Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]9211Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]10063Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]11109Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]11910Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]12541Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]14407Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]16273Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]22238Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (2M-H)-[-H2O]Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-1095Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-1103Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-1455Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-1771Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-2521Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-1095Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-1103Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-1455Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-1771Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-2521Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEMALTOSE (CAS# 69-79-4); (M+HCOO)-Peak areaPAK Untreated
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+1089Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+2760Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEBETA-MALTOSE (CAS# 69-79-4); (M+NA)+Peak areaPAK Untreated

Return to search page
  logo